Canada Approves Marijuana Extract Sativex for MS Spasticity
Posted by gestroud Tuesday, August 31, 2010 | 4 viewsHealth Canada has given final approval for the use of Sativex, a sublingual marijuana extract, for the treatment of spasticity in multiple sclerosis patients, the drug's manufacturer, GW Pharmaceuticals, announced Tuesday. Canada had previously approved Sativex for neuropathic pain in MS patients in 2005 and for pain relief in cancer patients in 2007.
[image:1 align:right caption:true]"This means that people in Canada with MS experiencing the debilitating symptoms of spasticity, such as painful spasms and cramps, will now have a new treatment option in addition to standard therapy," the company said in a press release.
The announcement comes as Sativex appears poised for a break-out. Already approved for use in Britain, it received preliminary approval earlier this month in Spain, and the German government announced two weeks ago that it would allow Sativex to apply for approval there. The company said it is also looking to market the drug in other European countries in association with Bayer.
"Following recent approvals in the UK and Spain, Canada is now the third major country to approve Sativex for symptomatic relief of spasticity in adult patients with MS," said Dr. Steven Wright, GW's research and development director. "This regulatory approval has come several months earlier than anticipated and GW looks forward to working with Bayer to develop the marketing strategy for this new indication."
Tags:
Canada, GW, Marijuana, MS, Spain
(No Ratings Yet)
Loading ...Leave a Reply
FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. It is being made available in an effort to advance the understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, and so on. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. If you wish to use copyrighted material from this site for purposes of your own that go beyond "fair use," you must obtain permission from the copyright owner.
The material in this site is provided for educational and informational purposes only, and is not intended to be a substitute for a health care provider's consultation. Please consult your own appropriate health care provider about the applicability of any opinions or recommendations with respect to your own symptoms or medical conditions. The information on this site does not constitute legal or technical advice.
(4.50 out of 5)
